We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

131 hedge funds and large institutions have $827M invested in Intra-Cellular Therapies Inc. in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 47 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more call options, than puts

Call options by funds: $49.9M | Put options by funds: $26.3M

19% more capital invested

Capital invested by funds: $692M → $827M (+$135M)

0% more funds holding

Funds holding: 131 → 131 (0)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

15% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 47

Holders
131
Holders Change
–
Holders Change %
0%
% of All Funds
2.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
40
Reduced
47
Closed
11
Calls
$49.9M
Puts
$26.3M
Net Calls
+$23.7M
Net Calls Change
+$8.87M

Top Buyers

1
Franklin Resources
Franklin Resources
California
+$10.3M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$9.3M
3
CS
Candriam SCA
Luxembourg
+$6.5M
4
FCM
Farallon Capital Management
California
+$5.23M
5
BlackRock
BlackRock
New York
+$2.79M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$11.4M
2
Millennium Management
Millennium Management
New York
-$8.5M
3
PC
PointState Capital
New York
-$8.39M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$8.36M
5
Deutsche Bank
Deutsche Bank
Germany
-$7.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
51
Bellevue Group
Switzerland
$1.19M -$529K -25,300 -32%
FSA
52
Franklin Street Advisors
North Carolina
$1.17M – – –
Group One Trading
53
Group One Trading
Illinois
$1.16M -$317K -15,145 -22%
Macquarie Group
54
Macquarie Group
Australia
$1.14M -$60.4K -2,889 -5%
New York State Common Retirement Fund
55
New York State Common Retirement Fund
New York
$1.11M – – –
HSBC Holdings
56
HSBC Holdings
United Kingdom
$1.05M +$769K +36,791 +318%
Renaissance Technologies
57
Renaissance Technologies
New York
$1.01M -$5.84M -279,076 -86%
State of Wisconsin Investment Board
58
State of Wisconsin Investment Board
Wisconsin
$990K – – –
Thrivent Financial for Lutherans
59
Thrivent Financial for Lutherans
Minnesota
$974K -$113K -5,413 -11%
PAM
60
Panagora Asset Management
Massachusetts
$969K -$3.41M -163,290 -79%
SG Americas Securities
61
SG Americas Securities
New York
$965K +$930K +44,454 New
RhumbLine Advisers
62
RhumbLine Advisers
Massachusetts
$920K -$192K -9,205 -18%
ARTA
63
A.R.T. Advisors
New York
$848K -$433K -20,700 -35%
SAMH
64
Shanda Asset Management Holdings
British Virgin Islands
$766K – – –
TCM
65
Tekla Capital Management
Massachusetts
$756K +$729K +34,850 New
Wolverine Trading
66
Wolverine Trading
Illinois
$751K +$486K +23,233 +204%
EIM
67
Essex Investment Management
Massachusetts
$724K +$28.9K +1,384 +4%
Simplex Trading
68
Simplex Trading
Illinois
$710K +$149K +7,135 +28%
EMG
69
ETF Managers Group
New Jersey
$696K +$172K +8,208 +34%
Royal Bank of Canada
70
Royal Bank of Canada
Ontario, Canada
$677K +$568K +27,168 +669%
PWM
71
Perigon Wealth Management
California
$651K – – –
AIG
72
American International Group
New York
$645K +$11.2K +537 +2%
Manulife (Manufacturers Life Insurance)
73
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$619K -$81.3K -3,886 -12%
ProShare Advisors
74
ProShare Advisors
Maryland
$603K -$22.9K -1,093 -4%
Barclays
75
Barclays
United Kingdom
$594K +$504K +24,120 +735%
1 2
3
4 5

ITCI Hedge Fund Activity: Q3 2018 in Review

131 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q3 2018, worth a combined $827M — up 19% from $692M a quarter earlier.

Fund positioning in ITCI was balanced in Q3 2018: 11 funds opened new positions, 11 closed out, 40 added to existing stakes and 47 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $10.3M. The largest seller was Citadel Advisors, cutting an estimated $11.4M.

  • 131 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $827M of Intra-Cellular Therapies Inc. stock for Q3 2018, up 19% quarter-over-quarter.
  • 11 funds opened new Intra-Cellular Therapies Inc. positions in Q3 2018 and 11 closed out, a net change of 0 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q3 2018 was Franklin Resources, an estimated $10.3M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q3 2018 was Citadel Advisors, an estimated $11.4M sold.

Based on aggregated 13F filings for Q3 2018.